Kristen Lantz

Subcutaneous versus intravenous daratumumab in patients with relapsed or refractory multiple myeloma (COLUMBA): a multicentre, open-label, non-inferiority, randomised, phase 3 trial

María‐Victoria Mateos, Hareth Nahi, Wojciech Legieć et al. · The Lancet Haematology · 2020 · 231 citations

Hematological Malignancy, Surgical Oncology, Medicine +6

Inhibition of PTP1B by Trodusquemine (MSI‐1436) Causes Fat‐specific Weight Loss in Diet‐induced Obese Mice

Kristen Lantz, Susan Hart, Sonia Lobo Planey et al. · Obesity · 2010 · 223 citations · Full text

Fat‐specific Weight Loss, Metabolic Disorder, Diet‐induced Obese Mice +19

Foxa2 regulates multiple pathways of insulin secretion

Kristen Lantz, Marko Z. Vatamaniuk, John Brestelli et al. · Journal of Clinical Investigation · 2004 · 163 citations · Full text

Pharmacokinetics of Daratumumab Following Intravenous Infusion in Relapsed or Refractory Multiple Myeloma After Prior Proteasome Inhibitor and Immunomodulatory Drug Treatment

Pamela L. Clemens, Xiaoyu Yan, Henk M. Lokhorst et al. · Clinical Pharmacokinetics · 2016 · 81 citations · Full text

<i>Foxa1</i>-Deficient Mice Exhibit Impaired Insulin Secretion due to Uncoupled Oxidative Phosphorylation

Marko Z. Vatamaniuk, Rana K. Gupta, Kristen Lantz et al. · Diabetes · 2006 · 60 citations · Full text

Uncoupled Oxidative Phosphorylation, Glucose Homeostasis, Foxa Genes +21